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Abstract: Angiogenesis represents an important process manifested in tumour growth and in development of metastases. Using
immunohistochemistry, the authors evaluated number of vessels in various nodular lesions of the thyroid (54 cases). Expression
of CD34 antigen and microvessel density were evaluated in sections of archival paraffin blocks originating from the Department
of Pathological Anatomy, University Medical School and the Lower Silesia Centre of Oncology in Wrocław, Poland.
Microvessel density was assessed in ten different fields per section in "hot spots". Expression of CD34 was quantified
using computerised image analysis and, then, mean micrvessel count (MVC) and microvessel area (MVA) were
calculated. In thyroid tissue with benign lesions, the MVC (31.7) was higher than in neoplastic lesions (22.3), although
no differences in MVA were observed. This observation points to differences in the size of newly formed vessels in individual
nodular lesions of the thyroid.
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Introduction
Angiogenesis involves formation of new blood vessels
from the preexisting vascular bed. It represents a multi-
stage process, related to modelling of the extracellular
matrix, proliferation and migration of endothelial cells,
differentiation and, then, anastomosing of capillaries
[10, 19]. The alterations remain under control of various
angiogenic factors. In physiological conditions, an-
giogenesis can be observed in developmental and re-
generative processes [10, 15, 17]. Abnormal and
unfavourable angiogenesis can be seen in pathological
processes, e.g. in the course of neoplastic growth. The
latter type of angiogenesis significantly affects prolife-
ration and metastasing potential of tumour cells [16, 17].
In many tumour types, angiogenesis has been noted to
be of prognostic significance. Its relation to develop-
ment of metastases was demonstrated for the first time
in malignant melanoma [14, 40]. Subsequently, studies
appeared which evaluated angiogenesis in tumours of
other organs, including larynx [22], lungs [18, 25, 44],
prostate [9, 31, 41], ovary [5], uterine cervix, kidney
[39], liver [28, 35] oesophagus, large intestine [3, 11,
13], urinary bladder [7, 21, 33, 36, 43] and haematologi-
cal disorders [6,10,12]. Neovascularisation in neoplastic
lesions, measured by density of microvessels, was found
to strictly correlate with metastatising potential in breast
cancer [8, 23]. The observations were confirmed in
many other solid tumours [8, 23].
Thyroid carcinomas are characterised by extensively
variable prognosis [1]: the most frequent papillary car-
cinoma carries a very good prognosis as to survival of
the patient, while the anaplastic carcinoma is burdened
by the lowest five-year survival values [20]. In several
studies, expression of vascular markers has been found
to correlate with tissue vascular supply and we used such
markers in our study to quantify microvessel density in
selected tumours of the thyroid [7-9].
This study was aimed at comparing density of the
vascular network, visualised by the expression of CD34
antigen, in benign and malignant thyroid lesions and in
individual types of thyroid tumours. 
Materials and methods
The study was performed on samples of thyroid lesions originating
from 54 patients. The material included 18 benign lesions (10 cases
of nodular goitre and 8 cases of follicular adenoma). In the other 36
patients, malignant tumours were diagnosed (9 cases of follicular
carcinoma, 23 cases of papillary carcinoma and 4 cases of medullary
carcinoma). Paraffin blocks originated from the Department of Pa-
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thological Anatomy, University Medical School in Wrocław and
from the Department of Pathomorphology, Lower Silesia Centre of
Oncology in Wrocław. All the patients were subjected to surgery in
the period 1992-2002 due to clinical symptoms of nodular goitre in
the absence of hyperthyroidism and on the basis of previous thin
needle biopsy or intraoperative histopathological examination. The
type of lesions was microscopically diagnosed according to WHO
criteria [20, 26, 29]. Before the surgery, the patients were not
subjected to therapy. 
The expression of CD34-positive cells was determined immuno-
histochemically in paraffin-embedded specimens fixed in 4% buf-
fered formalin. Histological slides, 4 µm in thickness, were
deparaffined in xylol. Slides were heated in 0.01 M citrate buffer
target retrieval solution (DAKO, Glostrup, Denmark, cat # N S1699)
3 × 10 min in microvave oven (700 W). After cooling for 20 min and
washing in PBS, endogenous peroxidase was blocked with methanol
containing 3% hydrogen peroxide for 5 min. The samples were
incubated with 1:50 dilution of monoclonal mouse anti-CD34 anti-
body (DAKO, Glostrup, Denmark, cat # N 1632), expressed on
vascular endothelium. After washing in PBS, the sections were
treated with streptavidin/peroxidase complex standard solution
(DAKO, LSAB 2, Denmark, cat # K 3468) for 20 min. Visualisation
of signal was achieved by incubation in a substrate solution com-
posed of 250 µL Tris pH 7.6, 2.5 ml diaminobenzidine tetrachloride
(DAB) and 1.7 µL 0.3 % H2O2 in 5 mL of double distilled H2O for
up to 2 min. Sections were counterstained with hematoxylin and
mounted. All procedures were carried out at room temperature.
At first under a light microscope, at a low magnification (× 40),
the studied lesions were screened to select regions which manifested
the highest density of microvessels (hot spots). The vessels were then
counted using × 200 magnification. CD34-positive vessels were
quantified using Olympus BX 50 light microscope with visual mode
and MultiScan 5.10 software for computer-assisted image analysis.
In every analysed case, total number of vessels present within the ×
200 magnification field (MVC) and area occupied by the stained
vessels in the same field (MVA) were established. In every case, the
measurements were performed in 10 representative fields and each
field was scored thrice. 
Results were subjected to statistical analysis using ANOVA and
Levene’s tests of variance and the STATISTICA software. For
benign and malignant lesions, mean values and standard deviations
were calculated for the number and area of vessels. Differences at
the level of p<0.05 were regarded as statistically significant. 
Results
In the histopathological material originating from 54
patients with nodular lesions of the thyroid, expression
of CD34 antigen was detected in the stroma of thyroid
follicles. Expression of the antigen included an evident
cytoplasmic reaction in endothelial cells. Any brown
stained endothelial cell or endothelial cluster clearly
separated from each other was considered a single
countable microvessel (Fig. 1). Evident, statistically sig-
nificant differences in microvessel count (MVC) were
disclosed between benign and malignant lesions (Tab.
1) and, less prominent ones, between malignant tumours
of different histological character (Tab. 2). Statistical
analysis of MVC in the primary tumours permitted to
group the tumours into three categories: lesions with
high MVC values, such as nodular goitre and follicular
adenoma, lesions with evidently lower MVC values
including follicular carcinoma and medullary carcinoma
and lesions with intermediate MVC values, i.e. papillary
carcinoma (Tab. 2). Evaluation and statistical analysis
of microvessel area (MVA) demonstrated no significant
differences. In turn, when both parameters, i.e., the
number of vessels and their area, were analysed in
parallel, the quantitative differences between benign and
malignant lesions and the differences between various
histological types of carcinomas were found to be related
mainly to the number of vessels, while their area showed
no significant differences. This observation points to
Table 1. Analysis of selected variables (number of vessels and vascular surface area) in benign and in malignant lesions of the thyroid. 
Variable
Benign lesion, n=18 Malignant lesion, n=36
mean SD mean SD
Number of vessels (MVC) 31.7 12.3 22.3* 8.4
Vascular surface area [mm2] (MVA) 0.307 0.132 0.267 0.117
*p<0.001
Table 2. Number of vessels and vascular surface area in individual histological types of studied thyroid lesions
Histological type of lesion
Number of vessels (MVC) Vascular surface area [mm2] (MVA)
mean SD mean SD
Nodular goitre, n=10 30.3 2 12.7 0.278 0.149
Follicular adenoma, n=8 33.5 2 12.3 0.344 0.105
Follicular carcinoma, n=9 18.7 5.2 0.266 0.135
Papillary carcinoma,  n=23 24.4 1 8.9 0.277 0.109
Medullary carcinoma,  n=4 18.0 8.9 0.210 0.143
1Significantly (p<0.05) different from follicular and medullary carcinomas; 2significantly (p<0.05) different from follicular, medullary
and papillary carcinomas.
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differences in the size of newly formed vessels in indi-
vidual nodular lesions of the thyroid. 
Discussion
Angiogenic potential of nodular (including neoplastic)
lesions of the thyroid has been a topic of studies aimed
at, i .a., defining prognosis and at applying appropriate
treatment, including anti-angiogenic therapy. In physio-
logical conditions and in normal organs, angiogenesis is
insignificant and remains at a stable level, typical for
a given tissue. For tumour development, formation of
new vessels represents an indispensable process
thought to be induced by activation of genes coding
for angiogenic factors [4, 10, 15, 17]. The density of
vascular network in selected tumours is evaluated by
employing immunohistochemical demonstrations of
various antigens (VEGF, CD34, CD31 and factor
VIII). Their expression visualises vessels in normal
tissues, pseudo-neoplastic hypertrophies and in neo-
Fig. 1. Visualisation of blood vessels in thyroid tumours using
anti-CD34 antibodies. a. Nodular goitre, note numerous blood ves-
sels of low diameter. b. Follicular adenoma, note very numerous
blood vessels of low diameter. c. Follicular carcinoma, note clearly
lower number of blood vessels as compared to follicular adenoma.
d. Papillary carcinoma, note blood vessels of a large calibre in the
connective tissue stroma of papillary forms. e. Medullary carcinoma,
note a low number of vessels. All figures × 200.
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plasms [7, 32, 35]. We used anti-CD34 antibody because
it requires a simple procedure and is effective in recog-
nizing small-caliber microvessels associated with neo-
vascularisation described as a "vasculogenic mimicry",
to emphasize de novo generation of blood vessels [9] and
is more efficient than other antibodies [7]. A widely
employed technique involves scoring of capillaries in
the most vascularised fields (hot spots) [7, 32, 34].
Comparability of fields selected for evaluation remains
a problem. Thyroid tumours, irrespectively of their his-
tological type, differ also between each other, showing
heterogeneity of various components of the neoplastic
tissue. For example, the papillary carcinoma of the thy-
roid may in various sites manifest either papillary or
vesicular structure. Heterogeneity of the thyroid neo-
plasms, application of various antibodies for visualisa-
tion of angiogenesis-associated antigens and application
of variable parameters of its evaluation may result in
divergent results and conclusions [27].
Our studies have shown that number of microvessels
demonstrates variability in individual histological types
of the lesions. In benign lesions of nodular goitre or
follicular adenoma types, the number of vessels ex-
ceeded that in malignant tumours (follicular carcinoma,
papillary carcinoma, medullary carcinoma). Among ma-
lignant tumours, the highest number of microvessels was
detected in papillary carcinoma. This might be ascribed
to the specific histological structure of the lesion, with a
strongly vascularised stalk of the papillary structures,
typical for morphology of these tumours. Thyroid papil-
lary carcinomas do not constitute a uniform group in
respect to their histological differentiation: low differen-
tiation types can also be distinguished, in which papil-
lary structures are few or absent, which may cause
difficulties in evaluation of angiogenesis intensity. In
our group of papillary carcinomas, highly mature types
have prevailed, with numerous papillary forms and with
stalks containing numerous vessels which, in our opi-
nion, has resulted in the observed high vascular density.
We also analysed the area of vascular surface (MVA)
which has not shown significant differences between
benign and malignant lesions. These data allow to con-
clude that angiogenesis accompanying benign, hyper-
trophic lesions involves formation of numerous vessels
of a low diameter while in malignant tumours less
numerous vessels of a larger diameter dominate. Ana-
lysis of the same parameter (MVA) in individual histo-
logical types of thyroid lesions has not demonstrated
significant differences, either. The area occupied by
vessels in individual nodular lesions of the thyroid was
similar in spite of differences in the number of the newly
formed microvessels. Also in the case of thyroid papil-
lary carcinoma, no significant increase could be demon-
strated in the vascular area. The largest and least
numerous vessels were observed in follicular and me-
dullary carcinomas. 
Reports in which angiogenesis has been studied in
thyroid tumours are not numerous. Wong et al. [45],
employing antibodies against CD34 in 15 tumours of
follicular adenoma type and 15 tumours of follicular
carcinoma type have noted that the two types cannot be
differentiated by comparisons of their vascular surface
area. Kumar Dhar et al. [29] evaluated angiogenesis in
71 differentiated thyroid carcinomas. They examined 16
cases of follicular carcinoma, 2 cases of papillary carci-
noma (follicular variant) and 53 cases of papillary car-
cinoma. Intensity of angiogenesis was evaluated by
reaction with anti-CD34 antibodies. The spread and
intensity of the reaction was evaluated by a semi-quan-
titative approach employing 0 to 3 scale for each of the
variables. The obtained results allowed to distinguish
two types of thyroid neoplasms: the hypovascular and
the hypervascular ones. The latter group included large
tumours (over 3 cm in diameter) with infiltration beyond
the thyroid. However, the vascular supply to the tumours
has not been analysed in relation to the histological type
of the tumours. Scarpino et al. [38] examined angiogen-
esis in 31 papillary carcinomas, monitoring expression
of von Willebrand factor. They detected a three-fold
higher density of vessels in non-neoplastic tissue strictly
adjacent to papillary carcinoma. They also stressed a
distinct type of vascular supply in papillary carcinomas,
resulting from location of the vessels in the form of
vascular complexes, resembling glomeruli in connective
tissue stroma of papillary structures. The authors sug-
gested that in papillary carcinomas, the vascular supply
of the tumour is initiated by extensive vascular spaces
with muscle fibres located in the peri-neoplastic fibrous
tissue. Similar conclusions were drawn by Akslen et al.
[2], who studied 128 papillary carcinomas and found
that angiogenesis evaluated by intensity of factor VIII
expression and by the area of the colour reaction was
three-fold higher in papillary carcinomas as compared
to the surrounding tissue, not affected by the tumour.
They detected also an inverse correlation between the
intensity of angiogenesis on one hand and patient age,
tumour size, histological grade of the lesion and ad-
vancement of the neoplastic process on the other.
They found that more pronounced angiogenesis was
accompanied by better prognosis. In the Polish lit-
erature of the subject we have found just one report
related to the density of vascular supply of the thyroid
[30]. The authors evaluated angiogenesis in 69 neo-
plastic and non-neoplastic lesions, examining ex-
pression of vascular endothelial growth factor
(VEGF). They detected positive immunohistochemi-
cal reaction only in a proportion of the lesions. The
intensity of the colour reaction, was evaluated semi-
quantitatively, and its type: diffuse or focal one was
also assessed. The authors detected low intensity of
the reaction in small regions of benign nodal lesions
(adenoma, nodular goitre) and a strong expression of
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VEGF in malignant tumours of the thyroid, except for
medullary carcinoma cases.
In our study, similarly to the above discussed experi-
ments with the use of markers permitting evaluation of
angiogenesis, application of immunohistochemistry
with the use of anti-CD34 antibodies allowed us to
demonstrate evident differences in the density of vascu-
lar supply between nodular lesions in the thyroid. The
density was related to the type of lesion (benign vs.
malignant) and to its histological variant. 
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